IL6 and myeloid sarcoma: As patients with obesity suffer from a chronic low-grade pro-inflammatory state (20) in which plasma levels of pro-inflammatory cytokines such as IL-6 are elevated (21), we explored whether IL-6 signaling mediates the association between BMI and risk of MS.